USPTO 2015–2025 USPTO PatentsView US Corporation

Nuvasive Specialized Orthopedics, Inc.

USPTO PatentsView assignee record - 97 granted patents across 13 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

18.8

Avg claims per patent

+159%

5-year filing velocity

The verdict

Nuvasive holds 97 US patents across 13 technology areas, rank #3,739 of 50,000 tracked assignees.

#3,739
of 50,000 US assignees by volume: Top 10%
by Innovation Score (52.4/100): 18.8
avg claims per patent: +159%
filing velocity, last 5 yrs

Portfolio overview

Nuvasive Specialized Orthopedics, Inc. has been granted 97 US utility patents between 2016 and 2025, placing Nuvasive Specialized Orthopedics, Inc. at rank #3,739 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Nuvasive Specialized Orthopedics, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Nuvasive sits between Koninklijke Philips Electronics Nv (97 patents, rank #3,735) and Orcam Technologies Ltd. (97 patents, rank #3,743) - the closest US assignees by grant volume. The composite Innovation Score of 52.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 70 grants, compared with 27 in the 2015–2019 window, a +159% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Nuvasive Specialized Orthopedics, Inc.'s 18.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Nuvasive Specialized Orthopedics, Inc. against peers pursuing similar technology classes.

Koninklijke Phili…

97
Korea Institute o…

97
LORD

97
Mobile Technology

97
New York Air Brake

97
Niantic

97
Novell

97
Orcam

97
Nuvasive Speciali… ◀

97

What this shows Nuvasive holds 97 patents at rank #3,739, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nuvasive

By rank, the assignees closest to #3,739 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Nuvasive's primary technology class.

Nuvasive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

52 Top 10% higher than 90% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Nuvasive Specialized Orthopedics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	5	5.2%
2017	5	5.2%
2018	6	6.2%
2019	11	11.3%
2020	7	7.2%
2021	7	7.2%
2022	17	17.5%
2023	12	12.4%
2024	18	18.6%
2025	9	9.3%

Which technologies does Nuvasive Specialized Orthopedics, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 85

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 29

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 5

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES 5

A61H - PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY 3

A61G - TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES 3

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 3

H04Q - SELECTING 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 1

G05B - CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS 1

H02J - CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY 1

G05G - CONTROL DEVICES OR SYSTEMS INSOFAR AS CHARACTERISED BY MECHANICAL FEATURES ONLY 1

Top 13 of 13 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#3,739

Across all tracked assignees

Innovation Score

52.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Nuvasive Specialized Orthopedics, Inc. hold?

Nuvasive Specialized Orthopedics, Inc. holds 97 US granted patents filed between 2016 and 2025, spanning 13 technology areas.

What is Nuvasive Specialized Orthopedics, Inc.'s Innovation Score?

Nuvasive Specialized Orthopedics, Inc. has an Innovation Score of 52.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nuvasive Specialized Orthopedics, Inc. focus on?

Nuvasive Specialized Orthopedics, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 85 patents. The company has filed patents in 13 CPC subclasses total.

Is Nuvasive Specialized Orthopedics, Inc.'s patent filing rate increasing or decreasing?

Nuvasive Specialized Orthopedics, Inc.'s recent filing velocity is +159% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Nuvasive Specialized Orthopedics, Inc.'s patents?

Nuvasive Specialized Orthopedics, Inc.'s patents average 18.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the Nuvasive Specialized Orthopedics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Nuvasive's 97 grants land it in the top 10% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Nuvasive ranks #3,739 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.